Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Basic, translational and clinical research
Review Submission guidelines
Cancer Nanotechnology conducts an initial suitability assessment of Reviews submitted to the journal to ensure that they are timely, relevant and of a sufficient standard expected of the journal. Authors of Reviews are required to answer the questions on the Review Submission guidelines in their cover letter.
Reviews that do not include this information in the cover letter will not be considered for publication in Cancer Nanotechnology.
Click here to view all the formatting guidelines
Articles
-
-
Advancing colorectal cancer therapy with biosynthesized cobalt oxide nanoparticles: a study on their antioxidant, antibacterial, and anticancer efficacy
-
Hypobaric hypoxia exposure regulates tissue distribution of nanomedicine for enhanced cancer therapy
-
A nano-cocktail of the PARP inhibitor talazoparib and CDK inhibitor dinaciclib for the treatment of triple negative breast cancer
-
Mild hyperthermia via gold nanoparticles and visible light irradiation for enhanced siRNA and ASO delivery in 2D and 3D tumour spheroids
-
Nanomedicine review: clinical developments in liposomal applications
-
Particle therapy and nanomedicine: state of art and research perspectives
-
Biological mechanisms of gold nanoparticle radiosensitization
-
Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications
-
Cisplatin-loaded hollow gold nanoparticles for laser-triggered release
Stay up to date
Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC.
Featured Article
Special article collections
Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far.
We welcome further submissions to these collections.
Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!
Latest Tweets
Your browser needs to have JavaScript enabled to view this timeline
Follow
Annual Journal Metrics
-
2022 Citation Impact
5.7 - 2-year Impact Factor
6.9 - 5-year Impact Factor
1.045 - SNIP (Source Normalized Impact per Paper)
0.882 - SJR (SCImago Journal Rank)2023 Speed
6 days submission to first editorial decision for all manuscripts (Median)
93 days submission to accept (Median)2023 Usage
328,851 downloads
109 Altmetric mentions
- ISSN: 1868-6966 (electronic)
- ISSN: 1868-6958 (print)